Workflow
华东医药: 浙江天册律师事务所关于华东医药股份有限公司2024年度股东大会的法律意见书
000963HUADONG MEDICINE(000963) 证券之星·2025-05-15 12:20

Core Viewpoint - The legal opinion letter from Zhejiang Tiance Law Firm confirms the legality and validity of the procedures, qualifications of attendees, and voting results for the 2024 annual general meeting of Huadong Medicine Co., Ltd. [1][6] Group 1: Meeting Procedures - The annual general meeting was proposed and convened by the board of directors, with the notice published on April 18, 2025, in designated media and on the Shenzhen Stock Exchange website [2][3] - The meeting utilized a combination of on-site and online voting, with the on-site meeting held at the company's new building on the third floor [2][3] - The specific times for online voting through the Shenzhen Stock Exchange platform were set for May 15, 2025, from 9:15 to 9:25, 9:30 to 11:30, and 13:00 to 15:00 [3] Group 2: Attendee Qualifications - Attendees included all registered ordinary shareholders of the Shenzhen branch, who could appoint proxies to attend and vote [4][5] - The qualifications of the shareholders and their proxies were verified against identification and authorization documents, confirming compliance with relevant laws and regulations [5] Group 3: Voting Procedures and Results - The voting was conducted in a named manner, with specific provisions for related shareholders to abstain from voting on certain proposals [6] - All proposals presented at the meeting were approved, and no additional matters not listed in the notice were voted on [6] - The voting procedures adhered to the requirements of the Company Law, Shareholder Meeting Rules, and the company's articles of association, ensuring the legality and validity of the results [6]